Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Accredo Health (ACDO) is in the process of buying Gentiva's Specialty Pharmaceutical Services (SPS) for $492 million, half in cash and half in Accredo stock. The SPS part of Gentiva accounts for half of their annual sales, has the higher net margin, and is the faster growing part of Gentiva. Accredo only wants the chronic medication part of the business and will rid itself of the acute business by the end of this year. Will Accredo sale the acute business back to Gentiva or will Gentiva simply be a home health nursing company? Does this answer your question?
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.